• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[利用21号染色体基因文库鉴定慢性粒细胞白血病中的一条标记染色体]

[Use of a chromosome 21 gene library in the identification of a marker chromosome in chronic myeloid leukemia].

作者信息

Cabello P, Speleman F, Ferro M T, Resino M, García-Sagredo J M, San Román C, Burgaleta M C

机构信息

Servicio de Genética Médica, Hospital Ramón y Cajal, Madrid.

出版信息

Sangre (Barc). 1992 Dec;37(6):457-9.

PMID:1293797
Abstract

The non-isotopic in situ hybridization makes it possible the analysis of, both, numeric and structural chromosome aberrations in interphase nuclei. Moreover, this technique is useful for identification of chromosome markers of unknown origin, frequently present in malignant diseases. In our case, the fluorescent in situ hybridization allowed us, in a CML patient in accelerated phase, to know the origin of a chromosome marker, and then, to state that the patient had a 21 trisomy added to the Philadelphia chromosome.

摘要

非同位素原位杂交使得分析间期核中的染色体数目和结构畸变成为可能。此外,该技术对于识别恶性疾病中常见的不明来源的染色体标记物很有用。在我们的案例中,荧光原位杂交使我们能够在一名加速期慢性粒细胞白血病患者中确定一个染色体标记物的来源,进而确定该患者除费城染色体外还存在21三体。

相似文献

1
[Use of a chromosome 21 gene library in the identification of a marker chromosome in chronic myeloid leukemia].[利用21号染色体基因文库鉴定慢性粒细胞白血病中的一条标记染色体]
Sangre (Barc). 1992 Dec;37(6):457-9.
2
Detection of trisomy 8 in philadelphia chromosome-positive CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques and its relation to c-myc involvement.运用传统细胞遗传学和间期荧光原位杂交技术检测费城染色体阳性慢性粒细胞白血病患者中的8号染色体三体及其与c-myc受累的关系。
Ann Clin Lab Sci. 2001 Jan;31(1):68-74.
3
A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.应用间期荧光原位杂交技术对慢性髓性白血病9号衍生染色体上ABL基因缺失发生率及其与疾病进展关系的研究
Genes Chromosomes Cancer. 2003 Jul;37(3):291-9. doi: 10.1002/gcc.10197.
4
Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.一名慢性粒细胞白血病急变期患者中BCR-ABL的扩增及t(3;21)
Cancer Genet Cytogenet. 2008 Jan 1;180(1):60-4. doi: 10.1016/j.cancergencyto.2007.09.014.
5
Determination of secondary chromosomal aberrations of chronic myelocytic leukemia.慢性粒细胞白血病继发性染色体畸变的测定
Cancer Genet Cytogenet. 2004 Aug;153(1):53-6. doi: 10.1016/j.cancergencyto.2003.12.013.
6
[Chromosome aberrations in chronic myeloid leukemia].[慢性髓性白血病中的染色体畸变]
Acta Haematol Pol. 1992;23(2 Suppl 1):5-12.
7
Megakaryocytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t(9;22;22) and a constitutional translocation t(3;7).一名慢性髓性白血病患者发生巨核细胞母细胞危象,该患者存在罕见的费城重排变异型t(9;22;22)和一种染色体组易位t(3;7)。
Cancer Genet Cytogenet. 2010 May;199(1):45-7. doi: 10.1016/j.cancergencyto.2010.01.017.
8
Fluorescence in situ hybridization (FISH) detection of trisomy 8 in myeloid cells in chronic myeloid leukemia (CML): a study of archival blood and bone marrow smears.慢性髓性白血病(CML)中髓细胞8号染色体三体的荧光原位杂交(FISH)检测:存档血液和骨髓涂片研究
Leukemia. 1994 Oct;8(10):1654-62.
9
Reciprocal relationship between a Ph-negative clone with trisomy 8 associated with severe myelodysplasia and a Ph-positive clone following imatinib treatment in a patient with accelerated-phase chronic myelogenous leukemia (CML).一名加速期慢性粒细胞白血病(CML)患者中,伴有严重骨髓增生异常的8号染色体三体阴性克隆与伊马替尼治疗后的Ph阳性克隆之间的相互关系。
Am J Hematol. 2004 Dec;77(4):420. doi: 10.1002/ajh.20226.
10
Translocation 3;21, trisomy 8, and duplication of the Philadelphia chromosome: a rare but recurrent cytogenetic pathway in the blastic phase of chronic myeloid leukemia.3号与21号染色体易位、8号染色体三体及费城染色体重复:慢性髓性白血病急变期一种罕见但反复出现的细胞遗传学途径。
Cancer Genet Cytogenet. 2007 Dec;179(2):159-61. doi: 10.1016/j.cancergencyto.2007.09.003.